Company Snapshot

Investment Thesis

Charles River Laboratories provides preclinical CRO services, research models, and manufacturing support for biopharma and biotech clients. Outsourcing trends, biologics demand, and high barriers to entry sustain growth.

  • Research Models: Global breeding network supplies essential lab animals.
  • Discovery & Safety: Integrated services accelerate drug pipelines.
  • Biologics Manufacturing: Cell and gene therapy support services.

Strategic Mix

Research Models & Services Animal models, lab services
Discovery & Safety Assessment Preclinical CRO
Manufacturing Solutions Microbial, cell/gene therapy
Customer Large pharma, biotech, academia

Mix mirrors CRL's three reporting segments.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Biotech Funding

Diversified client base mitigates venture volatility.

Capacity Expansion

Global campus investments support biologics demand.

ESG Compliance

Biosecurity and animal welfare programs sustain customer trust.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...